中东和非洲 miRNA 测序和检测市场预测至 2027 年 - COVID-19 影响和按产品(文库制备和耗材)、技术(合成测序、纳米孔和离子半导体测序)和最终用户(研究所、学术界和 CRO)

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 121    |    Report Code: TIPRE00022149    |    Category: Life Sciences

Middle East and Africa miRNA Sequencing and Assay Market

市场介绍

miRNA是一种20-30个核苷酸的小非编码RNA分子,在基因调控中发挥着重要作用。 miRNA 与信使 RNA (mRNA) 部分互补,其主要功能是下调基因表达。自从它们被发现以来,它们已成为重要细胞功能的重要调节者。 miRNA 与病毒感染、自身免疫性疾病和癌变等病理过程相关。

 

市场概况与动态

< p>中东和非洲miRNA测序和检测市场预计将从2019年的871万美元增至2027年的2200万美元;预计2020年至2027年复合年增长率为12.4%。microRNA的应用范围不断扩大,基因组学研究经费不断增加。然而,与基于 miRNA 的疗法的递送、功效和特异性相关的挑战阻碍了市场的增长。

miRNA 参与分化过程;它们作为识别细胞类型的有用标记发挥着至关重要的作用。 miRNA 与病毒感染、自身免疫性疾病和癌变等病理过程相关。因此,人们正在进行广泛的研究来鉴定新的 miRNA。此外,关于 miRNA 在疾病发展中的作用的发现使 miRNA 成为新型治疗方法的关键目标。几种针对癌症和肝炎等疾病的 miRNA 靶向疗法已进入临床阶段。例如,Santaris Pharma 开发了一种名为 Miravirsen 的治疗分子,靶向 miR-122,用于治疗丙型肝炎病毒(HCV)感染;该分子正处于 II 期临床试验中。因此,miRNA 应用范围的不断扩大正在推动 miRNA 测序和检测市场的增长。同样,中东和非洲地区用于识别新分子来诊断和治疗疾病的基因组研究资金的增加正在推动市场增长。

中东地区的国家正在正在经历 COVID-19 大流行的严重影响。各国封锁的初期影响了这些地区许多仪器和消耗品的供应。由于 COVID-19 病例激增,中东地区对新型诊断测试的需求不断增加,研究活动导致该地区更多地采用 miRNA 测序和检测程序。因此,持续的疫情对中东和非洲的 miRNA 测序和检测市场产生了积极影响。

 

主要细分市场

中东和非洲 miRNA 测序和检测市场按产品细分为文库制备和耗材。耗材细分市场在 2019 年占据了更大的市场份额,而文库制备细分市场预计在预测期内将实现更高的复合年增长率。

基于技术中东和非洲 miRNA 测序和检测市场分为合成测序、纳米孔测序和离子半导体测序。合成测序领域在 2019 年占据了最大的市场份额;然而,纳米孔细分市场预计在 2020 年至 2027 年期间将实现最高的复合年增长率。

根据最终用户,中东和非洲 miRNA 测序和检测市场分为研究机构、学术界和 CRO。研究机构细分市场在 2019 年占据了最大的市场份额,预计在此期间的市场复合年增长率最高。

 

主要来源和上市公司

< p>与本报告有关的关于 中东和非洲 miRNA 测序和检测市场的一些主要和次要来源是遗传工程和分子生物学研究所 (INGEBI)、世界卫生组织 (WHO) 和国际癌症研究机构 (IARC)。

 

 

span>

购买报告的理由

    < li>根据详细的趋势分析确定潜在投资领域中东和非洲 miRNA测序和分析市场< span> 未来几年。
  • 深入了解推动不同成瘾疗法需求的潜在因素成瘾疗法 支出最高的国家/地区的细分市场,并确定每个国家/地区提供的机会。
  • 加强您对市场需求驱动因素、行业趋势和最新技术的了解
  • 确定推动中东和非洲发展的主要渠道 中东和非洲 miRNA 测序和检测市场,提供了未来机遇的清晰图景,有助于分析,从而实现收入扩张。
  • 通过关注中东和非洲不同国家正在进行的项目来引导资源 miRNA 测序和检测市场< span>.

 

中东和非洲 miRNA 测序和检测市场细分

副产品

  • 文库准备
  • 耗材

按技术

  • 合成测序
  • 纳米孔
  • 离子半导体测序

最终用户

  • 研究院
  • 学术界
  • CRO< /li>

按国家/地区

  • 阿联酋
  • 沙特阿拉伯
  • 南非
  • 其他地区中东和非洲< /span>

公司简介

  • Illumina, Inc
  • Thermo FISHER SCIENTIFIC INC.
  • QIAGEN
  • Perkin Elmer, Inc.< /span>
  • Takara Bio Inc.
  • 新英格兰生物实验室
  • Norgen Biotek Corp
  • TriLink BioTechnologies Inc.
  • Lexogen GmbH
  • 牛津纳米孔技术


Middle East and Africa miRNA Sequencing and Assay Strategic Insights

Strategic insights for Middle East and Africa miRNA Sequencing and Assay involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-mirna-sequencing-and-assay-market-strategic-framework.webp
Get more information on this report

Middle East and Africa miRNA Sequencing and Assay Report Scope

Report Attribute Details
Market size in 2019 US$ 8.71 Million
Market Size by 2027 US$ 22.00 Million
Global CAGR (2020 - 2027) 12.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 文库制备
  • 耗材
By 技术
  • 测序合成
  • 纳米孔
  • 离子半导体测序
By 最终用户
  • 研究机构
  • 学术机构
  • CRO
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Illumina, Inc
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN
  • Perkin Elmer, Inc.
  • Takara Bio Inc.
  • New England Biolabs
  • Norgen Biotek Corp
  • TriLink BioTechnologies Inc.
  • Lexogen GmbH
  • Oxford Nanopore Technologies
  • Get more information on this report

    Middle East and Africa miRNA Sequencing and Assay Regional Insights

    The regional scope of Middle East and Africa miRNA Sequencing and Assay refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-mirna-sequencing-and-assay-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East and Africa miRNA Sequencing and Assay Market

    The List of Companies - Middle East and Africa miRNA Sequencing and Assay Market

    1. Illumina, Inc
    2. THERMO FISHER SCIENTIFIC INC.
    3. QIAGEN
    4. Perkin Elmer, Inc.
    5. Takara Bio Inc.
    6. New England Biolabs
    7. Norgen Biotek Corp
    8. TriLink BioTechnologies Inc.
    9. Lexogen GmbH
    10. Oxford Nanopore Technologies

     

    Frequently Asked Questions
    How big is the Middle East and Africa miRNA Sequencing and Assay Market?

    The Middle East and Africa miRNA Sequencing and Assay Market is valued at US$ 8.71 Million in 2019, it is projected to reach US$ 22.00 Million by 2027.

    What is the CAGR for Middle East and Africa miRNA Sequencing and Assay Market by (2020 - 2027)?

    As per our report Middle East and Africa miRNA Sequencing and Assay Market, the market size is valued at US$ 8.71 Million in 2019, projecting it to reach US$ 22.00 Million by 2027. This translates to a CAGR of approximately 12.4% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa miRNA Sequencing and Assay Market report typically cover these key segments-

  • 产品 (文库制备, 耗材)
  • 技术 (测序合成, 纳米孔, 离子半导体测序)
  • 最终用户 (研究机构, 学术机构, CRO)
  • What is the historic period, base year, and forecast period taken for Middle East and Africa miRNA Sequencing and Assay Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa miRNA Sequencing and Assay Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Middle East and Africa miRNA Sequencing and Assay Market?

    The Middle East and Africa miRNA Sequencing and Assay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Illumina, Inc
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN
  • Perkin Elmer, Inc.
  • Takara Bio Inc.
  • New England Biolabs
  • Norgen Biotek Corp
  • TriLink BioTechnologies Inc.
  • Lexogen GmbH
  • Oxford Nanopore Technologies
  • Who should buy this report?

    The Middle East and Africa miRNA Sequencing and Assay Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa miRNA Sequencing and Assay Market value chain can benefit from the information contained in a comprehensive market report.